What is Overt Diabetes Mellitus?
Overt diabetes mellitus (overt DM) refers to hyperglycemia that meets the full diagnostic criteria for diabetes in non-pregnant adults, as opposed to lesser degrees of glucose intolerance. In the context of pregnancy specifically, overt diabetes represents a more severe form of hyperglycemia first recognized during pregnancy that exceeds standard gestational diabetes thresholds 1, 2.
Diagnostic Criteria
General Population
Overt diabetes is diagnosed when any of the following criteria are met 1, 3:
- A1C ≥ 6.5% (48 mmol/mol) on two separate occasions
- Fasting plasma glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L)
- 2-hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during 75-g oral glucose tolerance test (OGTT)
- Random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) with classic symptoms of hyperglycemia (polyuria, polydipsia, unexplained weight loss)
In the absence of unequivocal hyperglycemia or hyperglycemic crisis, confirmation requires repeat testing 1, 3.
During Pregnancy
Overt diabetes in pregnancy (also called diabetes in pregnancy or DIP) is diagnosed at the first prenatal visit or during pregnancy when glucose levels meet non-pregnant diabetes thresholds 1, 2. This distinguishes it from gestational diabetes mellitus (GDM), which uses lower diagnostic cutoffs.
The specific criteria for overt diabetes in pregnancy include 2, 4:
- FPG ≥ 126 mg/dL (7.0 mmol/L), OR
- 2-hour glucose ≥ 200 mg/dL (11.1 mmol/L) on 75-g OGTT, OR
- HbA1c ≥ 6.5% (48 mmol/mol)
- Random glucose ≥ 200 mg/dL (11.1 mmol/L) with symptoms
Clinical Significance
Why the Distinction Matters
The term "overt" emphasizes that this represents frank diabetes rather than milder glucose intolerance. This distinction is particularly critical in pregnancy because:
Women with overt diabetes in pregnancy face substantially worse outcomes than those with standard GDM 2, 5, 6:
- 10-fold increased risk of postpartum type 2 diabetes (OR 10.69; 95% CI 5.32-21.48) 7
- 2.3-fold increased risk of metabolic syndrome postpartum 7
- Higher rates of preeclampsia (22% vs 3.7% in GDM) 5
- Increased premature birth (23.1% vs 6.7% in GDM) 5
- More large-for-gestational-age infants (40% vs 14.8% in GDM) 5
- Greater neonatal hypoglycemia and shoulder dystocia 4
Management Implications
Women with overt diabetes in pregnancy require more aggressive management than those with GDM 2:
- Earlier and more frequent monitoring
- Prompt insulin initiation (70% require insulin vs 15% with GDM) 8
- Higher insulin dosage requirements 4
- Closer postpartum surveillance
Postpartum Considerations
Not all women with overt diabetes in pregnancy have persistent diabetes postpartum 2, 4. Among those who undergo postpartum testing:
- 21% have persistent diabetes
- 37.6% have impaired fasting glucose or impaired glucose tolerance
- 41.4% return to normal glucose tolerance 4
Predictors of postpartum diabetes include 2:
- Early diagnosis (especially first trimester)
- FPG ≥ 126 mg/dL at initial diagnosis
Common Pitfalls
Do not use A1C for diagnosing diabetes during pregnancy for GDM screening purposes due to physiological changes in pregnancy that affect hemoglobin glycation 9. However, A1C ≥ 6.5% at the first prenatal visit does indicate overt diabetes.
Do not assume all hyperglycemia in pregnancy is GDM. Testing at the first prenatal visit in high-risk women can identify overt diabetes that requires different management 1.
Do not equate overt diabetes in pregnancy with pre-existing diabetes. These are women without known diabetes before pregnancy who meet diabetes criteria when first tested during pregnancy 2.
Recognize that 2-hour glucose on OGTT is a poor predictor of postpartum diabetes in this population, so comprehensive postpartum testing is essential 4.